Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Clinical Validation of HepatoPredict, a Prognostic Tool for Hepatic Surgery Based on a Molecular Signature

NCT06894524 is registered in ClinicalTrials.gov with Ophiomics as lead sponsor.

NCT NCT06894524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Clinical Validation of HepatoPredict, a Prognostic Tool for Hepatic Surgery Based on a Molecular Signature
Lead sponsor
Ophiomics
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
April 30, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepato cellular carcinoma (hcc), liver resection, liver transplantation